CONSUN PHARMACEUTICAL GRP LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of 1681 for the last semiannual is 1.59 B HKD, and it's 25.45% higher compared to the previous semiannual. The net income of H2 23 is 471.72 M HKD.